Brain Injury Research Group, University of Manchester, Greater Manchester, UK.
J Neurointerv Surg. 2013 Nov;5(6):512-7. doi: 10.1136/neurintsurg-2012-010386. Epub 2012 Sep 5.
The mechanism of development of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) is poorly understood. Inflammatory processes are implicated in the development of ischemic stroke and may also predispose to the development of DCI following SAH. The objective of this study was to test whether concentrations of circulating inflammatory markers (C-reactive protein (CRP), interleukin-6 (IL-6) and interleukin 1 receptor antagonist (IL-1Ra)) were predictive for DCI following SAH. Secondary analyses considered white cell count (WCC) and erythrocyte sedimentation rate (ESR).
This was a single-center case-control study nested within a prospective cohort. Plasma inflammatory markers were measured in patients up to 15 days after SAH (initial, peak, average, final and rate of change to final). Cases were defined as those developing DCI. Inflammatory markers were compared between cases and randomly selected matched controls.
Among the 179 participants there were 46 cases of DCI (26%). In primary analyses the rate of change of IL-6 was associated with DCI (OR 2.3 (95% CI 1.1 to 5.0); p=0.03). The final value and rate of change of WCC were associated with DCI (OR 1.2 (95% CI 1.0 to 1.3) and OR 1.3 (95% CI 1.0 to 1.6), respectively). High values of ESR were associated with DCI (OR 2.4 (95% CI 1.3 to 4.6) initial; OR 2.3 (95% CI 1.3 to 4.2) average; OR 2.1 (95% CI 1.1 to 3.9) peak; and OR 2.0 (95% CI 1.2 to 3.3) final value).
Leucocytosis and change in IL-6 prior to DCI reflect impending cerebral ischemia. The time-independent association of ESR with DCI after SAH may identify this as a risk factor. These data suggest that systemic inflammatory mechanisms may increase the susceptibility to the development of DCI after SAH.
尽管对动脉瘤性蛛网膜下腔出血(SAH)后迟发性脑缺血(DCI)的发病机制还知之甚少,但炎症过程与缺血性卒中的发生有关,也可能使 DCI 易于在 SAH 后发生。本研究的目的是检测循环炎症标志物(C-反应蛋白(CRP)、白细胞介素-6(IL-6)和白细胞介素 1 受体拮抗剂(IL-1Ra))的浓度是否可预测 SAH 后的 DCI。次要分析考虑了白细胞计数(WCC)和红细胞沉降率(ESR)。
这是一项单中心病例对照研究,嵌套于前瞻性队列研究中。在 SAH 后 15 天内测量患者的血浆炎症标志物(初始、峰值、平均、最终和最终变化率)。将发生 DCI 的患者定义为病例。比较病例与随机选择的匹配对照之间的炎症标志物。
在 179 名参与者中,有 46 例发生 DCI(26%)。在初步分析中,IL-6 的变化率与 DCI 相关(OR 2.3(95%CI 1.1 至 5.0);p=0.03)。WCC 的最终值和变化率与 DCI 相关(OR 1.2(95%CI 1.0 至 1.3)和 OR 1.3(95%CI 1.0 至 1.6))。高 ESR 值与 DCI 相关(初始时 OR 2.4(95%CI 1.3 至 4.6);平均时 OR 2.3(95%CI 1.3 至 4.2);峰值时 OR 2.1(95%CI 1.1 至 3.9);最终值时 OR 2.0(95%CI 1.2 至 3.3))。
DCI 发生前白细胞增多和 IL-6 变化反映了即将发生的脑缺血。SAH 后 ESR 与 DCI 的时间独立关联可能表明其为危险因素。这些数据表明,全身性炎症机制可能会增加 SAH 后发生 DCI 的易感性。